{"id":1068166,"date":"2021-12-31T01:42:14","date_gmt":"2021-12-31T06:42:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/akari-therapeutics-plc-announces-6-0-million-registered-direct-offering\/"},"modified":"2024-08-18T11:43:48","modified_gmt":"2024-08-18T15:43:48","slug":"akari-therapeutics-plc-announces-6-0-million-registered-direct-offering","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/akari-therapeutics-plc-announces-6-0-million-registered-direct-offering.php","title":{"rendered":"Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering"},"content":{"rendered":"<p><![CDATA[NEW YORK and LONDON, Dec.  30, 2021  (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (\u201cAkari\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and\/or leukotriene systems are implicated, today announced that it has entered into definitive agreements with institutional investors and accredited investors, led by existing investors of the Company, including Dr. Ray Prudo, the Company\u2019s Chairman, to receive gross proceeds of approximately $6.0 million.]]><\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/12\/30\/2359352\/0\/en\/Akari-Therapeutics-Plc-Announces-6-0-Million-Registered-Direct-Offering.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering\">Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Follow this link: Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/akari-therapeutics-plc-announces-6-0-million-registered-direct-offering.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068166","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068166"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068166"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068166\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}